Diamond Hill Capital Stock Portfolio: Top 10 Stock Picks
Heather Brilliant, CFA, serves as CEO for Diamond Hill Capital and joined the firm in 2019, bringing over 20 years of domestic and international investment industry experience to this role.
Abbott Laboratories (ABT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 11,277,123 | $1,275,555,453 | +2% | 0.5% |
| 2. | Diamond Hill Capital Ric Dillon | 6,551,533 | $741,043,898 | -2% | 3.27% |
| 3. | Sessa Capital John Petry | 4,006,723 | $453,200,439 | +7% | 16.24% |
| 4. | 3,098,000 | $350,414,780 | +71% | 0.06% | |
| 5. | BlueSpruce Investments Tim Hurd And Ed Magnus | 2,398,826 | $271,331,209 | 5.51% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $122.50 | 2,040 | 7,296 | 2021-02-23 | Filing | ||
| $73.40 | 2,000 | Officer | 52,562 | 2019-04-22 | Filing | |
| $72.32 | 100 | Director | 6,400 | 2019-01-31 | Filing | |
| $72.31 | 100 | Director | 6,300 | 2019-01-31 | Filing | |
| $72.33 | 1,800 | Director | 6,200 | 2019-01-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $136.65 | 200 | 71,928 | 2025-03-07 | Filing | ||
| $133.82 | 91,167 | 71,928 | 2025-03-06 | Filing | ||
| $138.17 | 949 | 74,381 | 2025-03-03 | Filing | ||
| $138.17 | 562 | 31,970 | 2025-03-03 | Filing | ||
| $138.17 | 1,111 | 66,878 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 168,645,397 | $19,075,480,822 | 0.33% | |
| 2. | 136,534,575 | $15,443,425,751 | 0.31% | |
| 3. | 77,167,682 | $8,728,366,599 | 0.34% | |
| 4. | 67,972,953 | $7,688,159,895 | 1.44% | |
| 5. | 54,097,005 | $6,118,902,856 | 1.25% |
News See All
15 Dividend Zombies to Invest in
The broader market has posted consecutive annual gains of 25%, largely fueled by growth stocks and companies capitalizing on the rising demand for artificial intelligence.
Jim Cramer Discusses These 10 Stocks & Says US Faces Unfairly High Tariffs Abroad
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer reiterated that the Trump administration has to clarify its narrative about tariffs to convince the average American about their utility...
10 Best Diabetes Stocks To Buy According to Billionaires
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income countries.
10 Best Healthcare Stocks For Long-Term Investment
In the US, healthcare expenditures and costs have been increasing. According to the Centers for Medicare & Medicaid Services, US healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023.
10 Best Drug Stocks to Buy Now
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.
Jim Cramer Shed Light on These 10 Stocks
Jim Cramer, host of Mad Money, recently offered some important advice on how young people should approach investing and managing their money.
10 Best Medical Device Stocks To Buy According to Hedge Funds
According to a report by Mordor Intelligence, the medical devices market has a size of $681.57 billion as of 2025.
Was Jim Cramer Right About These 12 Stocks?
Unlike the cash-rich tech giants that don’t need lower interest rates, small caps benefit tremendously from falling rates.
Jim Cramer Highlighted Buying Opportunities in 13 Stocks
Jim Cramer, the host of Mad Money, took a moment on Wednesday to reflect on the latest market developments as earnings season progresses, sharing his thoughts on how investors can identify stocks that...
Billionaire Hedge Funds
